Photo from Karima Oualla/LinkedIn
Sep 21, 2023, 17:56
Karima Oualla: We invite you to fill out this survey that takes no more than 3 minutes to complete.
Quoting Karima Oualla, Professor of Medical Oncology at Hassan II University Hospital, on LinkedIn:
“Dear Colleagues,
We are conducting a survey-based study on the preferences, experience, and common practices of oncologists about CDK4/6 inhibitors use in advanced ER+/HER2- breast cancer. In addition, we focus on the patterns and preferences for post-progression systemic therapies used.
This will help us to understand the disease and the response to treatment in a better way. We invite you to fill out this survey that takes no more than 3 minutes to complete.”
Source: Karima Oualla/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19